{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:24:27Z","timestamp":1789428267063,"version":"build-2803163510"},"reference-count":0,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Rep"],"published-print":{"date-parts":[[2010,10,26]]},"DOI":"10.3892\/or_00001026","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T10:42:08Z","timestamp":1288089728000},"source":"Crossref","is-referenced-by-count":39,"title":["Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA\/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity"],"prefix":"10.3892","volume":"24","author":[{"family":"Yamanegi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","container-title":["Oncology Reports"],"original-title":[],"link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or_00001026\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T09:02:38Z","timestamp":1493283758000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/or\/24\/6\/1621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,26]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,10,26]]}},"URL":"https:\/\/doi.org\/10.3892\/or_00001026","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,26]]}}}